199 related articles for article (PubMed ID: 22525512)
1. Bone matrix osteonectin limits prostate cancer cell growth and survival.
Kapinas K; Lowther KM; Kessler CB; Tilbury K; Lieberman JR; Tirnauer JS; Campagnola P; Delany AM
Matrix Biol; 2012 Jun; 31(5):299-307. PubMed ID: 22525512
[TBL] [Abstract][Full Text] [Related]
2. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
[TBL] [Abstract][Full Text] [Related]
3. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
4. Valproate reduces collagen and osteonectin in cultured bone cells.
Humphrey EL; Morris GE; Fuller HR
Epilepsy Res; 2013 Oct; 106(3):446-50. PubMed ID: 23906561
[TBL] [Abstract][Full Text] [Related]
5. Immunoelectron microscopy of osteonectin and type I collagen in osteoblasts and bone matrix.
Romanowski R; Jundt G; Termine JD; von der Mark K; Schulz A
Calcif Tissue Int; 1990 Jun; 46(6):353-60. PubMed ID: 2364322
[TBL] [Abstract][Full Text] [Related]
6. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells.
Chen N; Ye XC; Chu K; Navone NM; Sage EH; Yu-Lee LY; Logothetis CJ; Lin SH
Cancer Res; 2007 Jul; 67(14):6544-8. PubMed ID: 17638862
[TBL] [Abstract][Full Text] [Related]
7. Osteonectin-null mutation compromises osteoblast formation, maturation, and survival.
Delany AM; Kalajzic I; Bradshaw AD; Sage EH; Canalis E
Endocrinology; 2003 Jun; 144(6):2588-96. PubMed ID: 12746322
[TBL] [Abstract][Full Text] [Related]
8. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mateo F; Meca-Cortés O; Celià-Terrassa T; Fernández Y; Abasolo I; Sánchez-Cid L; Bermudo R; Sagasta A; Rodríguez-Carunchio L; Pons M; Cánovas V; Marín-Aguilera M; Mengual L; Alcaraz A; Schwartz S; Mellado B; Aguilera KY; Brekken R; Fernández PL; Paciucci R; Thomson TM
Mol Cancer; 2014 Oct; 13():237. PubMed ID: 25331979
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype.
Kasugai S; Todescan R; Nagata T; Yao KL; Butler WT; Sodek J
J Cell Physiol; 1991 Apr; 147(1):111-20. PubMed ID: 2037618
[TBL] [Abstract][Full Text] [Related]
10. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
Caley MP; Kogianni G; Adamarek A; Gronau JH; Rodriguez-Teja M; Fonseca AV; Mauri F; Sandison A; Rhim JS; Pchejetski D; Palmieri C; Cobb JP; Waxman J; Sturge J
J Pathol; 2012 Apr; 226(5):775-83. PubMed ID: 22072289
[TBL] [Abstract][Full Text] [Related]
11. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
Said N; Frierson HF; Chernauskas D; Conaway M; Motamed K; Theodorescu D
Oncogene; 2009 Oct; 28(39):3487-98. PubMed ID: 19597474
[TBL] [Abstract][Full Text] [Related]
12. Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins.
Lecrone V; Li W; Devoll RE; Logothetis C; Farach-Carson MC
Cell Calcium; 2000 Jan; 27(1):35-42. PubMed ID: 10726209
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.
Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N
Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612
[TBL] [Abstract][Full Text] [Related]
14. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
15. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
16. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathway for cancer metastasis to bone.
De S; Chen J; Narizhneva NV; Heston W; Brainard J; Sage EH; Byzova TV
J Biol Chem; 2003 Oct; 278(40):39044-50. PubMed ID: 12885781
[TBL] [Abstract][Full Text] [Related]
19. Increased Notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts.
Kessler CB; Delany AM
Endocrinology; 2007 Apr; 148(4):1666-74. PubMed ID: 17218421
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.
Zunich SM; Valdovinos M; Douglas T; Walterhouse D; Iannaccone P; Lamm ML
Mol Cancer; 2012 Jul; 11():30. PubMed ID: 22559324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]